NSC |
Compound |
Enrichment |
Correlation |
NSC 686554 |
9H-Quino[4,3,2-de][1,10]phenanthrolin-9-one, 2-(2-pyridinyl)- |
0.0130238833303634 |
0.34793252 |
NSC 688228 |
Null |
0.0130238833303634 |
0.12748799 |
NSC 6926 |
Null |
0.0130238833303634 |
0.25378962 |
NSC 693037 |
Null |
0.0130238833303634 |
0.12281079 |
NSC 709358 |
1H-Pyrrole-2-carboxamide, N-[3-(dimethylamino)propyl]-1-methyl-4-[[[1-methyl- 4-[[1-oxo-4-[[(2,3,5,11a-tetrahydro-7-methoxy-5-oxo- 1H-pyrrolo[2,1-c][1,4]benzodiazepin-8-yl]oxy]butyl]amino]- 1H-pyrrol |
0.0130238833303634 |
0.12492651 |
NSC 718781 |
Erlotinib hydrochloride |
0.0130238833303634 |
-0.14980528 |
NSC 726217 |
Combretastatin A4-analogue |
0.0130238833303634 |
0.44686708 |
NSC 732962 |
5-amino-4-(1,3-benzothiazol-2-yl)-1-(2-chloro-5-trifluoromet hylphenyl)-2,3-dihydro-1H-3-pyrrolone |
0.0130238833303634 |
0.31528928 |
NSC 740357 |
Null |
0.0130238833303634 |
-0.11877631 |
NSC 87864 |
N-Salicylidene-N-salicyloylhydrazine |
0.0130238833303634 |
0.20219001 |